期刊
GUT PATHOGENS
卷 13, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s13099-021-00407-7
关键词
Angiotensin-converting enzyme 2; Gut-lung axis; Gut-microbiome; Opportunistic pathogens; Probiotics; SARS-CoV-2
资金
- Department of Biotechnology under BioCARe scheme [BT/PR30603/BIC/101/1104/2018]
- JC Bose fellowship
COVID-19 patients may have SARS-CoV-2 present in their nasopharyngeal and stool samples. The gut microbiota plays a crucial role in immune response and could be a significant factor in the prognosis of COVID-19.
COVID-19 is an acute respiratory distress syndrome and is often accompanied by gastrointestinal symptoms. The SARS-CoV-2 has been traced not only in nasopharyngeal and mid-nasal swabs but also in stool and rectal swabs of COVID-19 patients. The gut microbiota is important for an effective immune response as it ensures that unfavorable immune reactions in lungs and other vital organs are regulated. The human gut-lung microbiota interplay provides a framework for therapies in the treatment and management of several pulmonary diseases and infections. Here, we have collated data from COVID-19 studies, which suggest that bacterial co-infections as well as the gut-lung cross talk may be important players in COVID-19 disease prognosis. Our analyses suggests a role of gut microbiome in pathogen infections as well as in an array of excessive immune reactions during and post COVID-19 infection recovery period.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据